Home Tools
Log in
Cart

Disease Focused

These include focused libraries of small-molecule compounds with potential biological activity towards certain diseases (such as Anti-Cancer Compound Library, Anti-Diabetic Compound Library, Anti-Cardiovascular Disease Compound Library, etc.).

Cat No. product name
L1800 Anti-Infection Compound Library A unique collection of 2977 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc; 2977 compounds
L2620 Anti-Neurodegenerative Disease Compound Library A unique collection of 1622 compounds related to neurodegenerative diseases can be used for HTS or HCS; 1622 compounds
L2191 Anti-Breast Cancer Compound Library A unique collection of 1436 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study; 1436 compounds
L9840 Anti-Alzheimer's Disease Compound Library A unique collection of 1040 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS. 1040 compounds
L2170 Immuno-Oncology Compound Library A unique collection of 454 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening; 454 compounds
L4710 Nonsteroidal Anti-Inflammatory Compound Library 530 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening. 530 compounds
L4700 Immunology/Inflammation Compound Library A unique collection of 3483 anti-inflammation compounds effective for high throughput screening and high content screening. 3483 compounds
L1719 Nsp15-Targeted Compound Library (CADD) A unique collection of 470 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; 470 compounds
L4510 Anti-Parasitic Compound Library 525 well-chosen unique anti-parasitic small molecules; 525 compounds
L2180 Anti-Cancer Library Plus Well-chosen 1468 anti-tumor compounds with unique structures; 1468 compounds
L1900 Anti-Diabetic Compound Library A unique collection of 690 diabetes related compounds; 690 compounds
L1715 Nsp16-Targeted Compound Library (CADD) A unique collection of 281 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; 281 compounds
L2152 Targeted Therapy Drug Library 121 tumor-targeted drugs that can be used for high-throughput and high-content screening. 121 compounds
L2192 Anti-Pancreatic Cancer Compound Library A unique collection of 1697 pancreatic cancer related compounds can be used in HTS and HCS; 1697 compounds
L4660 Anti-Nervous System Disease Library Well-chosen 1246 compounds with unique structures targeting nervous system; 1246 compounds
L1716 PLpro-Targeted Compound Library (CADD) A unique collection of 474 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; 474 compounds
L4520 Anti-Bacterial Compound Library A unique collection of 1429 antibacterial bioactive compounds, a powerful tool for antibacterial drug development; 1429 compounds
L9810 Anti-Fibrosis Compound Library A unique collection of 1180 potential anti-fibrosis compounds, can be used in HTS and HCS; 1180 compounds
L1714 RBD-Targeted Compound Library (CADD) A unique collection of 206 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; 206 compounds
L5400 Anti-Cardiovascular Disease Compound Library A unique collection of 1428 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS); 1428 compounds
L2120 Anti-Cancer Clinical Compound Library A unique collection of 1990 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS); 1990 compounds
L1710 Anti-COVID-19 Compound Library A unique collection of 2446 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents; 2446 compounds
L2160 Anti-Cancer Active Compound Library A unique collection of 2114 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); 2114 compounds
L2151 Chemotherapy Drug Library 51 Chemotherapeutic drugs that can be used for high-throughput and high-content screening. 51 compounds
L9830 Anti-Parkinson's Disease Compound Library A unique collection of 908 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS. 908 compounds
L8400 Hematonosis Compound Library A unique collection of 524 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS); 524 compounds
L2140 Cancer Cell Differentiation Compound Library A unique collection of 413 cancer cell differentiation inducing compounds for high throughput and high content screening; 413 compounds
L7110 Anti-Hypertension Compound Library 719 hypertension-related small molecules for high-throughput and high-content screening. 719 compounds
L2100 Anti-Cancer Compound Library A unique collection of 5885 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); 5885 compounds
L2150 Anti-Cancer Drug Library A unique collection of 2478 anticancer drugs for high throughput screening (HTS) and high content screening (HCS); 2478 compounds
L1700 Anti-Virus Compound Library A unique collection of 800 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening; 800 compounds
L1717 RdRP-Targeted Compound Library (CADD) A unique collection of 464 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; 464 compounds
L4500 Anti-Fungal Compound Library A unique collection of 253 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation. 253 compounds
L2110 Anti-Cancer Approved Drug Library A unique collection of 1726 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS); 1726 compounds
L7100 Anti-Obesity Compound Library A unique collection of 1359 anti-obesity compounds for high throughput and high content screening; 1359 compounds
L1711 Anti-COVID-19 Compound Library (CADD) A unique collection of 362 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; 362 compounds
L2190 Anti-Lung Cancer Compound Library A unique collection of 1566 compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study; 1566 compounds
L1718 X Domain-Targeted Compound Library (CADD) A unique collection of 463 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; 463 compounds
L1712 3CLpro-Targeted Compound Library (CADD) A unique collection of 161 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; 161 compounds
L5200 Anti-Metabolism Disease Compound Library A unique collection of 1558 metabolism diseases related compounds for high throughput screening (HTS) and high content screening (HCS); 1558 compounds
L2130 Anti-Cancer Metabolism Compound Library A unique collection of 1280 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS); 1280 compounds
L1713 ACE2-Targeted Compound Library (CADD) A unique collection of 462 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; 462 compounds
Anti-Infection Compound Library
L1800 compounds - 2977
Anti-Neurodegenerative Disease Compound Library
L2620 compounds - 1622
Anti-Breast Cancer Compound Library
L2191 compounds - 1436
Anti-Alzheimer's Disease Compound Library
L9840 compounds - 1040
Immuno-Oncology Compound Library
L2170 compounds - 454
Nonsteroidal Anti-Inflammatory Compound Library
L4710 compounds - 530
Immunology/Inflammation Compound Library
L4700 compounds - 3483
Nsp15-Targeted Compound Library (CADD)
L1719 compounds - 470
Anti-Parasitic Compound Library
L4510 compounds - 525
Anti-Cancer Library Plus
L2180 compounds - 1468
Anti-Diabetic Compound Library
L1900 compounds - 690
Nsp16-Targeted Compound Library (CADD)
L1715 compounds - 281
Targeted Therapy Drug Library
L2152 compounds - 121
Anti-Pancreatic Cancer Compound Library
L2192 compounds - 1697
Anti-Nervous System Disease Library
L4660 compounds - 1246
PLpro-Targeted Compound Library (CADD)
L1716 compounds - 474
Anti-Bacterial Compound Library
L4520 compounds - 1429
Anti-Fibrosis Compound Library
L9810 compounds - 1180
RBD-Targeted Compound Library (CADD)
L1714 compounds - 206
Anti-Cardiovascular Disease Compound Library
L5400 compounds - 1428
Anti-Cancer Clinical Compound Library
L2120 compounds - 1990
Anti-COVID-19 Compound Library
L1710 compounds - 2446
Anti-Cancer Active Compound Library
L2160 compounds - 2114
Chemotherapy Drug Library
L2151 compounds - 51
Anti-Parkinson's Disease Compound Library
L9830 compounds - 908
Hematonosis Compound Library
L8400 compounds - 524
Cancer Cell Differentiation Compound Library
L2140 compounds - 413
Anti-Hypertension Compound Library
L7110 compounds - 719
Anti-Cancer Compound Library
L2100 compounds - 5885
Anti-Cancer Drug Library
L2150 compounds - 2478
Anti-Virus Compound Library
L1700 compounds - 800
RdRP-Targeted Compound Library (CADD)
L1717 compounds - 464
Anti-Fungal Compound Library
L4500 compounds - 253
Anti-Cancer Approved Drug Library
L2110 compounds - 1726
Anti-Obesity Compound Library
L7100 compounds - 1359
Anti-COVID-19 Compound Library (CADD)
L1711 compounds - 362
Anti-Lung Cancer Compound Library
L2190 compounds - 1566
X Domain-Targeted Compound Library (CADD)
L1718 compounds - 463
3CLpro-Targeted Compound Library (CADD)
L1712 compounds - 161
Anti-Metabolism Disease Compound Library
L5200 compounds - 1558
Anti-Cancer Metabolism Compound Library
L2130 compounds - 1280
ACE2-Targeted Compound Library (CADD)
L1713 compounds - 462